Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recurrence of Graves' Disease: What Genetics of HLA and PTPN22 Can Tell Us.

Frontiers in endocrinology - 1 Jan 2021

Vejrazkova Daniela, Vcelak Josef, Vaclavikova Eliska, Vankova Marketa, Zajickova Katerina, Vrbikova Jana, Duskova Michaela, Pacesova Petra, Novak Zdenek, Bendlova Bela

Abstract excerpt

Background: Approximately half of patients diagnosed with Graves' disease (GD) relapse within two years of thyreostatic drug withdrawal. It is then necessary to decide whether to reintroduce conservative treatment that can have serious side effects, or to choose a radical approach. Familial forms of GD indicate a significant genetic component. Our aim was to evaluate the practical benefits of HLA and PTPN22...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Gene Frequency

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Graves Disease

Share to Haplotypes

Share to Histocompatibility Antigens Class I

Share to Protein Tyrosine Phosphatase, Non-Receptor Type 22

Share to Recurrence

Source

Open in PubMed Open full text

Identifiers

PMID: 34887833
DOI: 10.3389/fendo.2021.761077
PMCID: PMC8650699

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recurrence of Graves' Disease: What Genetics of HLA and PTPN22 Can Tell Us.PMID 34887833Read ↗

Outcome of Graves’ Disease and Associated Genetic Predisposition: A Systematic Review of LiteratureSemantic proximity Read ↗

Genotype and Phenotype Predictors of Relapse of Graves’ Disease after Antithyroid Drug WithdrawalSemantic proximity Read ↗

The predictive value of CTLA-4 and Tg polymorphisms in the recurrence of Graves' disease after antithyroid withdrawal.Semantic proximity Read ↗

Certain HLA alleles are associated with stress-triggered Graves' disease and influence its course.Semantic proximity Read ↗

Genetic markers in diagnosis and prediction of relapse in Graves' disease.Semantic proximity Read ↗

The genetics of Graves' disease.Semantic proximity Read ↗

Cytotoxic T lymphocyte-associated molecule-4 gene polymorphism and hyperthyroid Graves' disease relapse after antithyroid drug withdrawal: a follow-up study.Semantic proximity Read ↗

Role of genetic and non-genetic factors in the etiology of Graves' disease.Semantic proximity Read ↗

Significance of HLA in the development of Graves’ orbitopathySemantic proximity Read ↗

DQA2 U allele: a genetic marker for relapse of Graves' disease.Semantic proximity Read ↗

Significance of HLA in the development of Graves' orbitopathy.Semantic proximity Read ↗

Cytotoxic T lymphocyte-associated molecule-4 polymorphism and relapse of Graves' hyperthyroidism after antithyroid withdrawal.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.